ArticleVaccines2024

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens.

Pedro Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.